.avif)
Penn Medicine Email Format
Hospitals and Health Care
・
25,001-50,000 employees
・
Philadelphia, PA, USA
Penn Medicine is a leading academic medical center headquartered in Philadelphia, operating seven hospitals and providing patient care, medical research, and health education across Pennsylvania and New Jersey.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@uphs.upenn.edu
Company Overview
Industry
Hospitals and Health Care
Founded
1751
Headquarters
Philadelphia, PA, USA
Revenue
$5B-$10B
FUNDING Stage
Non Profit
Website
Key Executives
Kevin Mahoney (Chief Executive Officer, University of Pennsylvania Health System), Julia Puchtler (Senior Vice President and Chief Financial Officer), Michele Volpe (Sr. Vice President and Chief Operating Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Penn Medicine?
Penn Medicine uses the first.last format, so Jane Smith would be jane.smith@uphs.upenn.edu.
What hospitals are part of the Penn Medicine health system?
Penn Medicine operates seven hospitals across Pennsylvania, Delaware, and New Jersey, including flagship facilities in Philadelphia and Penn Medicine Lancaster General Health in Lancaster, PA, along with 13 multispecialty centers and hundreds of outpatient locations.
How many people does Penn Medicine employ?
Penn Medicine employs approximately 21,892 people across its health system and academic medical center operations. You can use Clay to build a targeted list of Penn Medicine contacts and verify their details before outreach.
Who leads Penn Medicine as its chief executive?
Kevin Mahoney serves as Chief Executive Officer of the University of Pennsylvania Health System, a role he has held since July 2019 after spending more than two decades in various leadership positions at Penn Medicine.
What is Penn Medicine's Abramson Cancer Center known for in 2026?
The Abramson Cancer Center at Penn Medicine is a national leader in CAR T cell therapy and cancer genetics research, with Penn researchers presenting advances in CAR T and cancer interception at major oncology conferences in 2026, including AACR and ASCO.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating